Stockhead on MSN13h
The storied Australian drug developer turning his skills to funds managementThe co-developer of a US-approved drug, Professor Andrew Wilks has formed Synthesis Bioventures to sniff out more winners.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback